Please assess the completion status of the following clinical trial:

Trial Title: Spatial Analysis and Validation of Glioblastoma on 7 T MRI

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Supratentorial tumour~* Suspected GBM on diagnostic MRI~* Eligible for biopsy~* Minimum age 18 years or older~* World Health Organization (WHO) Performance scale ≤2~* American Society of Anaesthesiologist (ASA) class ≤ 3~* Understanding of the Dutch language~* Ability to comply to study procedure~Exclusion Criteria:~* Recurrent tumour~* Tumour location deemed unfit for extra biopsies~* Prior radiotherapy to the skull~* Prior chemotherapy~* World Health Organization (WHO) Performance scale ≥ 3~* American Society of Anaesthesiologist (ASA) class ≥ 3~* Eligibility for immediate debulking~* Contra-indications for gadolinium~* Contra-indications for the MRI

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Biopsy (Type: EXPERIMENTAL): Subjects will receive a 7 T MRI and one additional biopsy to their standard diagnostic biopsies

Based on this trial design, predict the completion outcome and termination type (if applicable).